Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

FHS
May 23, 2024
11:00 pm

Increasing the intake of flavonoid-rich foods significantly reduces the risk of developing type 2 diabetes, according to a study in Nutrition & Diabetes.

Formycon announces EMA acceptance of the MAA for FYB203, a biosimilar candidate to Eylea® (Aflibercept) – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Admission Formycon announces EMA acceptance of the MAA for FYB203, a biosimilar candidate to Eylea® (Aflibercept) 27.12.2023 /

December 28, 2023

MR-139 by Viatris for Blepharitis: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 4, 2024

Opinion | ‘The Real Risk Is a Bad Trip’: What We Heard This Week

“The real risk is a bad trip.” — Smita Das, MD, PhD, MPH, of Stanford University in California, on the risks of off-label ketamine use.

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.